Symptoms I cannot really explain with their idea: flu like symptoms, sensory overload (but you have that in migraines, too, hm), sleep disruption, delayed PEM...
INTRODUCTION
An infectious epidemic outbreak, characterized by acute onset of severe influenza like symptoms and accompanied by severe venous involvement, occurred in 1975 in a community hospital in Carmichael, a suburb of Sacramento, CA. Vascular features ranged from spontaneous bruising with numbness, tingling, and burning to painfully swollen veins. The severity of disease appeared to be associated with the extent of vascular sequelae. The hallmark symptom of painful veins appeared to be similar but more severe and extensive than the Epidemic Phlebodynia documented in three other hospital epidemics reported in 1953, 1957, and 1965 (1-3). Headaches, sore throat, fever, dizziness, runny nose, nausea and vomiting, severe exhaustion and weakness, severe generalized pain, disturbances of cognition/mentation, and nervous system abnormalities resembled Epidemic Neuromyasthenia (ENM), Chronic Fatigue Syndrome (CFS) and Myalgic Encephalomyelitis (ME). Today these illnesses are thought to represent the same and/or a spectrum of related disease states.
In summary, while the outbreak had many features resembling the documented diseases described in this report, the “infectious venulitis”, severity of pain and symptoms, and long-term disability suggest that it may be a more virulent form of these illnesses or that the outbreak may represent a new disease entity. Indeed, the observed vasculopathy, severe generalized pain, dementia, severe neurologic findings, and peri-articular disease may suggest that this illness is disparate from CFS. Regardless, the information gleaned from the 1975 outbreak will add to the growing body of literature to an illness that has long been trivialized despite its devastating sequelae.
But then, every responder and every non-responder is providing clues to the astute as of why one is responding or not. And we have astute researchers.
One question for @Jonathan Edwards if I may, would Cyclophosphamide kill plasma cells and could that make a difference between responding and non-responding?
And for @deleder2k do you know if non-responders to Rituximab have been given Cyclo?
But then, every responder and every non-responder is providing clues to the astute as of why one is responding or not. And we have astute researchers.
And for @deleder2k do you know if non-responders to Rituximab have been given Cyclo?
I'm not keen on Fluge and Mella's hypothesis re blood vessels, but I'm open to possibilities, and the main thing is whether the treatment works or not. They must have their reasons for the hypothesis, and I can see how autoantibodies that affect blood vessels could potentially induce brain fog and neurological symptoms, but I'm struggling to see how it could invoke flu-like and other immunological symptoms, unless a lack of blood flow to regions of the brain (e.g. pituitary/hypothalamus) might interfere with immunological function.
@deleder2k
Hi, any ideas about time frame for when this open label ritux publishing might be out? I know it is a long shot but just in case there is a general time frame.
NERVES IN THE NOSE.
There was a programme on the radio recently which mentioned some nerves in the nose which can cause a variety of symptoms if they are malfunctioning.
If they were affected by a virus , could they cause some of the brain fog, cognitive dysfunction etc etc?
Thank you. I'll see if I can find out more by doing some googling. (Sorry if I seem to be ignoring the topic. It's just that this reminded me of this)Some nerves in the nose have an open connection with the brain.
Professor Edwards, mind if I ask, what are some of the challenges involved in trying to identify an autoantibody in this situation?Oystein thinks some patients may have autoantibodies targeting molecules involved in fine regulation of blood flow - I think partly in relation to OI but also brain fog and 'feeling as if running a marathon'. He has been interested in nitric oxide but I do not think he would want to predict a precise target molecule.